Results 51 to 60 of about 3,083,119 (212)

Psychedelic Therapy Versus Antidepressants for Treating Chronic Depression [PDF]

open access: yes, 2022
More than 18 million people in the United States suffer from depression, making it the number one cause of disability. Depression is the primary reason why every 14 minutes someone dies from suicide, creating an epidemic.
Struppe, Lasse   +2 more
core  

Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.

open access: yesPLoS ONE
BackgroundPsychedelic-assisted therapies hold early promise for treating multiple psychiatric conditions. However, absent standards for the care, teams providing psychedelic-assisted therapy pose a major roadblock to safe administration.
Caroline Peacock   +9 more
doaj   +1 more source

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research

open access: yesFrontiers in Psychiatry, 2021
Background: Chronic Pain is among the leading causes of disability worldwide with up to 60% of patients suffering from comorbid depression. Psychedelic-assisted therapy has recently been found effective in treating a host of mental health issues ...
Julia Bornemann   +5 more
doaj   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

open access: yesAddiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock   +8 more
wiley   +1 more source

Exploring Psychedelic-Assisted Therapy and Sex Therapy Through the Lens of Optimal Sex and Attachment: A Potential for Transformative Healing

open access: yes, 2022
Psychedelic-assisted therapy and sex therapy are two fringe disciplines within psychology that have yet to be merged. However, psychedelic-assisted therapy is showing promising results in healing underlying issues related to sexual concerns such as ...
Bain, Kristina
core  

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions

open access: yes, 2023
Background: Psychedelic-assisted therapy has gained significant attention in recent years. However, there is a lack of empirical clarity on the role of psychosocial interventions (PI) in clinical trials of psychedelic treatment due in part to ...
Alexander B. Belser   +2 more
core   +1 more source

Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology [PDF]

open access: yes, 2023
Psychedelic-assisted psychotherapy is being investigated as a treatment for a range of psychiatric illnesses. Current research suggests that the kinds of subjective experiences induced by psychedelic compounds play key roles in producing therapeutic ...
Miceli McMillan, Riccardo   +3 more
core   +1 more source

Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder

open access: yesFrontiers in Psychiatry
Psychedelic-assisted therapy is a remarkably promising treatment for substance use disorders and for alcohol use disorder (AUD) in particular. Research supporting psychedelics as a safe and effective pharmacotherapy for AUD and its comorbid psychiatric ...
Scott Matthews   +11 more
doaj   +1 more source

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder

open access: yesFrontiers in Psychiatry, 2023
IntroductionPsychedelic-assisted therapy with psilocybin has shown promise in Phase 2 trials for alcohol use disorder (AUD). Set and setting, particularly factors facilitating a connection with nature, may positively influence the psychedelic experience ...
Keith G. Heinzerling   +11 more
doaj   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy